NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Spinal injection of immunotherapy shows promise for hard-to-treat brain metastasis
Disease control OngoingThis early-phase study tests whether injecting two immunotherapy drugs directly into the spinal fluid, along with standard IV doses, is safe and can shrink tumors in the brain and spinal cord lining. It includes 26 adults with advanced lung cancer or melanoma that has spread to t…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New biosimilar aims to match keytruda for lung cancer treatment
Disease control OngoingThis study tests whether SB27, a biosimilar drug, works as well as Keytruda for people with advanced non-squamous non-small cell lung cancer. About 555 participants will receive either SB27 or Keytruda along with chemotherapy every 3 weeks. The main goal is to see if the tumor sh…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE3 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:08 UTC